Palo Alto Investors »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $41M 349k 117.07

More positions owned by Palo Alto Investors

Ptc Therapeutics I (PTCT)
ACADIA Pharmaceuticals (ACAD)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Anaptysbio Inc Common (ANAB)
BioMarin Pharmaceutical (BMRN)
Dyne Therapeutics (DYN)
United Therapeutics Corporation (UTHR)
Disc Medicine (IRON)
Biogen Idec (BIIB)
Iovance Biotherapeutics (IOVA)
Ultragenyx Pharmaceutical (RARE)
Novocure Ord Shs (NVCR)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)

View all positions for Palo Alto Investors

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Tenor Capital Management
Capstone Investment Advisors
Readystate Asset Management
Bnp Paribas Arbitrage, Snc
BlackRock
Polar Securities
FMR
Lazard Asset Management
Aequim Alternative Investments
Jpmorgan Chase & Co
Bank Of Montreal
Nicholas Investments Partners
MacKay Shields
Advent Capital Management
Warberg Asset Management

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0